Valuation Ipca Laboratories Limited

Stocks

Market Closed - NSE India S.E. Other stock markets 07:05:08 2026-06-25 EDT			5-day change	1st Jan Change
1,618.30 ^INR	-0.18%		+2.05%	+14.05%

06-26	Ipca Laboratories Limited agreed to acquire remaining 50.35% stake in Krebs Biochemicals & Industries Limited for INR 612 million.	CI
06-01	Ipca Laboratories Limited, Q4 2026 Earnings Call, Jun 01, 2026

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	241,495	270,385	205,589	313,934	381,038	410,570	-	-
Change	-	11.96%	-23.96%	52.7%	21.38%	7.75%	-	-
Enterprise Value (EV) ¹	239,835	275,070	201,870	325,349	391,231	408,673	396,073	386,910
Change	-	14.69%	-26.61%	61.17%	20.25%	4.46%	-2.34%	-2.31%
P/E	21.1x	30.6x	43.6x	57.4x	51.6x	35.6x	29.4x	24.7x
PBR	5.14x	4.92x	2.58x	4.96x	5.48x	5.04x	4.37x	3.79x
PEG	-	-1.4x	-0.9x	3.6x	1.5x	0.7x	1.2x	1.3x
Capitalization / Revenue	4.46x	4.64x	3.29x	4.07x	4.26x	4.21x	3.81x	3.42x
EV / Revenue	4.43x	4.72x	3.23x	4.22x	4.38x	4.24x	3.68x	3.22x
EV / EBITDA	15.5x	21x	21.8x	24.6x	22.7x	20.7x	16.8x	14.2x
EV / EBIT	18x	25.6x	30.3x	33.8x	29.5x	26.2x	20.9x	17.6x
EV / FCF	32.9x	72.9x	64.8x	60.9x	71.7x	83.5x	41.7x	35.2x
FCF Yield	3.04%	1.37%	1.54%	1.64%	1.4%	1.2%	2.4%	2.84%
Dividend per Share ²	4	8	4	4	2	6	5.792	6.258
Rate of return	0.42%	0.75%	0.49%	0.32%	0.13%	0.37%	0.36%	0.39%
EPS ²	45.06	34.85	18.58	21.57	29.08	44.98	55.01	65.51
Distribution rate	8.88%	23%	21.5%	18.5%	6.88%	13.3%	10.5%	9.55%
Net sales ¹	54,200	58,298	62,443	77,050	89,396	96,463	107,715	120,158
EBITDA ¹	15,444	13,073	9,268	13,212	17,261	19,786	23,587	27,340
EBIT ¹	13,352	10,748	6,652	9,639	13,283	15,604	18,929	22,039
Net income ¹	11,400	8,841	4,713	5,474	7,377	11,411	14,037	16,700
Net Debt ¹	-1,660	4,685	-3,720	11,415	10,193	2,442	-14,496	-23,660
Reference price ²	951.88	1,065.75	810.35	1,237.40	1,501.90	1,618.30	1,618.30	1,618.30
Nbr of stocks (in thousands)	253,704	253,704	253,704	253,704	253,704	253,704	-	-
Announcement Date	5/28/21	5/24/22	5/29/23	5/29/24	5/29/25	5/29/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
IPCA LABORATORIES LIMITED	36.36x	4.2x	20.4x	0.31%	4.35B
ELI LILLY AND COMPANY	35.2x	12.84x	26.1x	0.57%	1,077B
JOHNSON & JOHNSON	27.22x	6.26x	17.02x	2.1%	613B
ABBVIE INC.	32.17x	7.47x	15.29x	2.73%	448B
ROCHE HOLDING AG	17.9x	4.45x	10.94x	2.98%	332B
ASTRAZENECA PLC	23.72x	4.94x	14x	1.76%	293B
NOVARTIS AG	21.69x	5.59x	13.51x	2.83%	286B
NOVO NORDISK A/S	14.19x	5.21x	10.72x	3.54%	215B
AMGEN INC.	23.3x	6.21x	10.84x	2.81%	193B
GILEAD SCIENCES, INC.	-45.82x	5.53x	30.47x	2.54%	159B
Average	18.59x	6.27x	16.93x	2.22%	362.04B
Weighted average by Cap.	24.46x	7.94x	18.32x	1.97%